Press Release – EYLEA HD Phase 3 Trial results (QUASAR trial)
Eylea HD injection of 8 gm in the Phase 3 trial (QUASAR trial) is meeting the primary endpoints showing improved vision with extended dosing intervals in patients with macular…
Eylea HD injection of 8 gm in the Phase 3 trial (QUASAR trial) is meeting the primary endpoints showing improved vision with extended dosing intervals in patients with macular…